ANNUAL REPORT AND ACCOUNTS 2014 Portfolio Summary During 2014, the Group, together with third parties, deployed $125.
0 million of capital into the Companys businesses, which includes, together with the ordinary course annual funding of the subsidiaries, the $10.
0 million invested in ABLS at formation, and the equity financing transactions at STT $70.
Allied Minds currently has majority ownership in, or operating control of, all of its subsidiary investments, and continues to invest in and support its most promising companies.
Below we provide an overview of our current existing subsidiary companies, including year formed, and Allied Minds ownership interest.
Year Ownership 1 Subsidiary Formed Interest Overview Life Sciences Allied-Bristol Life Sciences, LLC 2014 80.
00% Created with Bristol-Myers Squibb to identify and foster research and preclinical development of biopharmaceutical innovations, and convert discoveries from university research institutions into therapeutic candidates for clinical development ABLS I, LLC 2014 80.
00% Formed to execute the first ABLS project approved for investment: this project involves licensing intellectual property with respect to prostate oncology from an Ivy League institution, and proceeding to pre-clinical evaluation and development ABLS II, LLC 2014 80.
00% Formed to execute the second ABLS project approved for investment: this project involves licensing intellectual property with respect to fibrotic diseases from a second Ivy League institution, and proceeding to pre-clinical evaluation and development Biotectix, LLC 2007 64.
35% Aiming to enable the next generation of implantable electrostimulation and sensing products through the development of proprietary, high-performance, conducting polymer coatings Cephalogics, LLC 2006 95.
00% Developing a non-invasive, bedside neuroimaging system, which seeks to improve monitoring of patients with neurological injury CryoXtract Instruments, LLC 2008 93.
24% A suite of automated product solutions that seeks to allow the global scientific community to access valuable frozen biosamples without exposing them to damaging freeze thaw cycles Page 16 of 152 c111026.
indb 16 25 04 2015 02:07 Strategic Report ANNUAL REPORT AND ACCOUNTS 2014 Portfolio Summary continued Year Ownership 1 Subsidiary Formed Interest Overview Life Sciences continued LuxCath, LLC 2012 98.
00% A catheter-based real-time tissue and lesion visualisation technology for potential use during cardiac ablation procedures initially focused on atrial fibrillation ablation Precision Biopsy, LLC 2008 80.
35% A medical device platform utilising tissue spectroscopy, which seeks to distinguish tissue characteristics in real-time and seeks to guide clinicians toward areas of disease for optimum therapy initially focused on prostate cancer ProGDerm, Inc. d b a Novare 2008 90.
38% A biologic that aims to represent a natural Pharmaceuticals approach to generate subcutaneous fat to enhance the appearance of skin using the bodys own processes SciFluor Life Sciences, Inc. 2010 69.
94% Developing a portfolio of proprietary compounds by harnessing the transformational power of fluorine with a view to optimising drug discovery and accelerating the clinical development of innovative new therapeutics SoundCure, Inc. 2009 84.
62% Developed an FDA-cleared consumer medical device for tinnitus therapy offering customised acoustic technology High Technology Allied Minds Federal 2012 100.
00% Through a series of public-private partnerships Innovations, Inc. PPPs with the US federal government, aims to develop and commercialise the next generation of transformative technologies from US federal research institutions BridgeSat, Inc. 2015 100.
00% Developing an optical connectivity system that aims to increase the speed, security and efficiency of data transmissions from Low Earth Orbit LEO satellites compared to traditional radio frequency solutions Page 17 of 152 c111026.
indb 17 25 04 2015 02:07 ANNUAL REPORT AND ACCOUNTS 2014 Portfolio Summary continued Year Ownership 1 Subsidiary Formed Interest Overview High Technology continued Federated Wireless, Inc. 2012 90.
88% Focused on enabling technologies for the next-generation of wireless communications by seeking to improve supply, demand, and delivery of spectrum for future cellular communications Foreland Technologies, Inc. 2013 100.
00% A cyber security platform company which aims to discover, incubate and commercialise emerging technologies Optio Labs, Inc. 2012 81.
23% Developer of mobile security technologies for the evolving cyber operating environment Percipient Networks, LLC 2014 100.
00% Developing next-generation security technologies for enterprise network defence RF Biocidics, Inc. 2008 67.
14% Developer of equipment that seeks to disinfect food from insects and pathogens through a process that does not use chemicals Seamless Devices, Inc. 2014 79.
85% Developer of semiconductor devices using a novel approach to analog signal processing, building upon patented switched-mode signal processing technology and algorithms SiEnergy Systems, LLC 2007 100.
00% Developing thin film low temperature solid oxide fuel cells that seek to bring efficient, and affordable clean energy systems for broad application Spin Transfer Technologies, Inc. 2007 48.
40% MRAM computer memory that is being developed with the aspiration of becoming a leading universal memory technology in the $60 billion per annum worldwide computer memory market Whitewood Encryption 2014 100.
00% Develop the next-generation systems of data Systems, Inc. encryption that leverage advanced quantum cryptography technologies uniquely capable of meeting intensifying market demand for secure, computationally efficient, and lowlatency encryption Notes: 1 Ownership interests are as at 27 April 2015 being the latest practicable date prior to the publication of this Annual Report.
Allied Minds ownership of SciFluor was 79.
00% as at 31 December 2014, prior to a funding round involving both Allied Minds and external investors of $30.
Allied Minds ownership of Optio Labs was 79.
86% as at 31 December 2014, prior to its final contribution and purchase of shares in January 2015 in the $10.
Allied Minds ownership of Seamless Devices was 80.
00% as at 31 December 2014, prior to an exercise of employee stock options that reduced its ownership percentage.
